Enanta Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2016 - 2020
Operating Revenue	65.32	67.64	79.2	86.16	97.07	Upgrade
Revenue	65.32	67.64	79.2	86.16	97.07	Upgrade
Revenue Growth (YoY)	-3.42%	-14.61%	-8.07%	-11.24%	-20.74%	Upgrade
Gross Profit	65.32	67.64	79.2	86.16	97.07	Upgrade
Selling, General & Admin	43.93	57.85	52.89	45.48	32.54	Upgrade
Research & Development	106.74	131.48	163.52	164.52	174.11	Upgrade
Operating Expenses	150.67	189.33	216.41	210	206.65	Upgrade
Operating Income	-85.35	-121.69	-137.21	-123.84	-109.57	Upgrade
Interest Expense	-7.68	-10.94	-5.15	-	-	Upgrade
Interest & Investment Income	9.95	13.63	8.5	2.74	2.02	Upgrade
Other Non Operating Income (Expenses)	0.04	0.07	-	0.08	-0.03	Upgrade
EBT Excluding Unusual Items	-83.05	-118.93	-133.85	-121.02	-107.58	Upgrade
Gain (Loss) on Sale of Investments	-0.5	1.14	2.86	-1.17	-	Upgrade
Pretax Income	-83.55	-117.79	-131	-122.19	-107.58	Upgrade
Income Tax Expense	-1.66	-1.74	2.82	-0.43	-28.58	Upgrade
Net Income	-81.89	-116.05	-133.82	-121.76	-79	Upgrade
Net Income to Common	-81.89	-116.05	-133.82	-121.76	-79	Upgrade
Shares Outstanding (Basic)	21	21	21	21	20	Upgrade
Shares Outstanding (Diluted)	21	21	21	21	20	Upgrade
Shares Change (YoY)	0.85%	0.90%	1.78%	2.14%	1.16%	Upgrade
EPS (Basic)	-3.84	-5.48	-6.38	-5.91	-3.92	Upgrade
EPS (Diluted)	-3.84	-5.48	-6.38	-5.91	-3.92	Upgrade
Free Cash Flow	-32.17	-96.71	-112.21	-86.91	-70.75	Upgrade
Free Cash Flow Per Share	-1.51	-4.57	-5.35	-4.22	-3.51	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-130.66%	-179.92%	-173.23%	-143.74%	-112.88%	Upgrade
Profit Margin	-125.36%	-171.58%	-168.95%	-141.31%	-81.38%	Upgrade
Free Cash Flow Margin	-49.24%	-142.99%	-141.67%	-100.87%	-72.88%	Upgrade
EBITDA	-80.76	-119.36	-134.84	-120.87	-106.24	Upgrade
EBITDA Margin	-123.63%	-176.47%	-170.24%	-140.29%	-109.44%	Upgrade
D&A For EBITDA	4.59	2.34	2.37	2.97	3.33	Upgrade
EBIT	-85.35	-121.69	-137.21	-123.84	-109.57	Upgrade
EBIT Margin	-130.66%	-179.92%	-173.23%	-143.74%	-112.88%	Upgrade
Revenue as Reported	65.32	67.64	79.2	86.16	97.07	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q